Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasuo Terauchi, Iseki Takamoto, Naoto Kubota, Junji Matsui, Ryo Suzuki, Kajuro Komeda, Akemi Hara, Yukiyasu Toyoda, Ichitomo Miwa, Shinichi Aizawa, Shuichi Tsutsumi, Yoshiharu Tsubamoto, Shinji Hashimoto, Kazuhiro Eto, Akinobu Nakamura, Mitsuhiko Noda, Kazuyuki Tobe, Hiroyuki Aburatani, Ryozo Nagai, Takashi Kadowaki
Published in Volume 117, Issue 1
J Clin Invest. 2007; 117(1):246–257 doi:10.1172/JCI17645
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
Insufficient β cell hyperplasia in Irs2+/– mice on the HF diet.

(AC) Body weight (A), fasting blood glucose (B), and serum insulin (C) values of wild-type and Irs2+/– mice after 10 weeks on standard chow or HF diet (n = 5–8). (D) Insulin tolerance in wild-type and Irs2+/– mice after 10 weeks on standard chow or HF diet (n = 4–8). (E and F) Area of β cells in each islet (E) and maximum islet diameter (F) in wild-type and Irs2+/– mice after 10 weeks on standard chow or HF diet. We examined 100–150 islets from 3 animals per group. Values represent mean ± SEM. *P < 0.05; **P < 0.01.